Which micronutrient deficiency is most commonly seen in patients on long-term proton pump inhibitor (PPI) the… - GMCH Nursing Officer-2025

GMCH Nursing Officer-2025

Pharmacology

Easy

Appeared in: GMCH Nursing Officer-2025

Explanation

Long-term use of proton pump inhibitors (PPIs) suppresses gastric acid production, leading to hypochlorhydria (low stomach acid).
An acidic environment is necessary for the proper absorption of several minerals, but the mechanism for magnesium absorption is particularly affected.
The change in gastrointestinal pH impairs the function of intestinal channels (TRPM6/7) responsible for active magnesium transport.
This impaired absorption can lead to clinically significant hypomagnesemia, a well-documented adverse effect requiring monitoring and sometimes supplementation.
The U.S. FDA has issued a specific safety warning regarding the risk of low serum magnesium levels with prolonged PPI use.

Option A: While iron absorption is also reduced by low stomach acid and can lead to deficiency with long-term PPI use, clinically significant hypomagnesemia is a more emphasized and specific risk that has prompted regulatory warnings.
Option B: Zinc absorption is not primarily dependent on gastric acid. It is more affected by dietary components like phytates, which bind to zinc and prevent its absorption.
Option D: The absorption of Vitamin C, a water-soluble vitamin, is not significantly impaired by the reduction in stomach acid caused by PPIs.

Visual 1: Flowchart - A flowchart illustrating the pathway: Long-term PPI Use → Decreased Gastric Acid → Impaired Intestinal Magnesium Absorption → Hypomagnesemia → Clinical Symptoms (e.g., muscle cramps, arrhythmias).
Visual 2: Infographic - An infographic listing common signs and symptoms of hypomagnesemia to help nurses with patient assessment.

Clinical Relevance

Nursing practice connection: Knowing Adverse effects and micronutrient deficiencies from long-term PPI therapy helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Nurses must monitor serum magnesium levels in patients on long-term PPI therapy, especially if they are symptomatic or have other risk factors.
Patient education is crucial. Nurses should teach patients to recognize symptoms of hypomagnesemia (e.g., muscle spasms, weakness, seizures) and report them immediately.
It is important to assess for concomitant use of other drugs that can lower magnesium, such as diuretics, as this can severely increase the risk of hypomagnesemia.

How to Approach the Question

First, identify the drug class in the question: Proton Pump Inhibitors (PPIs).
Recall the primary mechanism of action for this drug class: They potently suppress gastric acid secretion.
Think about the physiological role of gastric acid. A key function is to help with the absorption of certain minerals and vitamins.
Evaluate the options based on this mechanism. Which micronutrient's absorption is known to be significantly dependent on an acidic environment?
Consider the options: Iron, Magnesium, and Vitamin B12 are all affected by stomach acid to some degree. However, hypomagnesemia is a distinct and well-publicized adverse effect of long-term PPI use, making it the most likely correct answer in an exam context.

Concept Tested & Keywords

Concept Tested: Adverse effects and micronutrient deficiencies from long-term PPI therapy
Stem keywords: micronutrient deficiency, long-term, proton pump inhibitor, PPI
Lead-in keywords: most commonly seen

QZbYqH2ZGa5cuwE7gA7Yso